This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Chiesi Farmaceutici S.p.a., Vectura Gmbh. Active years: 2010-2012.
Company Filing History:
Years Active: 2010-2012
Title: Rosella Musa: Innovator in Pharmaceutical Formulations
Introduction
Rosella Musa is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of dry powder inhalers. With a total of 2 patents, her work focuses on enhancing the delivery of active ingredients to patients.
Latest Patents
One of her latest patents is titled "Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient." This invention provides a formulation designed for efficacious delivery of low-dosage strength active ingredients to the low respiratory tract of patients. The formulation comprises microparticles made of a low-dosage strength active ingredient and excipient microparticles, with a mass median diameter (MMD) between 2 and 15 microns. Notably, at least 10% of the microparticles have a mass diameter (MD) greater than 0.5 microns, ensuring effective inhalation.
Another significant patent is the "Method of making particles for use in a pharmaceutical composition." This method involves a milling step where excipient material particles are milled in the presence of an additive material. The resulting product particles are small in size, and the milling process requires relatively low input of time and energy. These composite particles are suitable for use in inhalable pharmaceutical compositions.
Career Highlights
Throughout her career, Rosella Musa has worked with notable companies in the pharmaceutical industry, including Vectura GmbH and Chiesi Farmaceutici S.p.A. Her expertise in pharmaceutical formulations has made her a valuable asset in these organizations.
Collaborations
Rosella has collaborated with esteemed colleagues such as John Nicholas Staniforth and Roberto Rastelli. These partnerships have contributed to her innovative work in the field.
Conclusion
Rosella Musa is a trailblazer in the development of pharmaceutical formulations, with a focus on improving inhalation therapies. Her patents reflect her commitment to advancing healthcare solutions for patients.